In the most recent trading session, Tenet Healthcare (THC) finished at $125.44, which is a decrease of 0.46% compared to the previous day.
THC is putting more emphasis on ASCs to meet the increasing need for outpatient services.
Consider investing in healthcare stocks such as WGS, THC, RIGL, and ENSG for consistent returns, especially as attention turns to the healthcare policies of the upcoming Trump administration.
At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. At the same time, we keep an eye on the most recent trends in value, growth, and momentum to support our top selections.
THC anticipates that its net operating revenues will be between $20.6 billion and $21 billion in 2025.
Tenet Healthcare Corporation (NYSE:THC) will hold its Q4 2024 Earnings Conference Call on February 12, 2025, at 10:00 AM ET. The call will feature company representatives, including Will McDowell, Saumya Sutaria, and Sun Park, as well as participants from various financial institutions. The operator will begin the call by welcoming everyone to the conference.
Tenet Healthcare (THC) reported quarterly earnings of $3.44 per share, which is higher than the Zacks Consensus Estimate of $2.93 per share. This is an increase compared to earnings of $2.68 per share from the same period last year.
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) has released its financial results for the quarter ending December 31, 2024. Saum Sutaria, M.D., Chairman and CEO of Tenet, stated that 2024 was a remarkable year for the company, marked by strong revenue growth, effective operations, high patient satisfaction, and improvements in clinical quality, along with significant changes to their portfolio that helped reduce debt. He emphasized that their targeted strategy and disciplined operations contributed to this success.
THC's results for the fourth quarter are expected to show an increase in patient admissions, usage, and the number of days patients spend there.
To better understand how Tenet (THC) might perform in the quarter ending December 2024, look beyond Wall Street's basic profit and loss predictions. Instead, focus on the estimates for some of its important metrics. This will give you a clearer picture of its potential performance.